v3.26.1
Intangible Assets, Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Aug. 13, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Intangible Asset, Net [Line Items]        
Achievement of milestones $ 3,320      
Product basis rate   5.00%    
Proceedings of equity   $ 5,000    
Percentage of sublicenses   25.00%    
Issued initial public offering   $ 4,720 $ 3,408
Warrants issued upon IPO     266 $ 310
Intangible asset carrying value   2,547 2,884  
Impairment loss recognized     37  
Amortization expense for intangible assets   300 $ 116  
Pre-funded warrants [Member]        
Intangible Asset, Net [Line Items]        
Warrants issued upon IPO   243    
Warrant [Member]        
Intangible Asset, Net [Line Items]        
Warrants issued upon IPO   $ 1,369    
License [Member]        
Intangible Asset, Net [Line Items]        
Estimate useful life   10 years    
License Agreement [Member]        
Intangible Asset, Net [Line Items]        
Fair value of shares committed to be issued   $ 3,000    
SciSparc [Member]        
Intangible Asset, Net [Line Items]        
Ordinary shares issued (in Shares)   213    
Preclinical safety test [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 50,000      
Phase 1 Clinical Trial [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 100,000      
Phase 2a Clinical Trial [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 120,000      
Phase 2b Clinical Trial [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 150,000      
Phase 3 Clinical Trials [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 500,000      
FDA [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 800,000      
EU Regulatory Body [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones 800,000      
Additional Jurisdiction Clinical [Member]        
Intangible Asset, Net [Line Items]        
Achievement of milestones $ 800,000      
IPO [Member]        
Intangible Asset, Net [Line Items]        
Issued initial public offering   $ 3,000